Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia.

Support Care Cancer

OhioHealth Breast Surgeons, 285 East State Street, Suite 300, Columbus, OH, 43215, USA.

Published: March 2024

AI Article Synopsis

  • Scalp cooling is a non-drug method to reduce hair loss from chemotherapy, and this study aimed to evaluate the effectiveness of a manual cold capping system across different patient demographics.
  • A total of 100 patients tried cold capping, with 95% completing the process; the median hair retention reported was 75%, and 92.1% experienced favorable outcomes (retaining at least 50% of their hair).
  • The only factor affecting hair retention success was the type of chemotherapy used, with patients on doxorubicin-containing regimens having lower success rates compared to those on paclitaxel or docetaxel regimens; race or hair characteristics did not impact results.

Article Abstract

Background: Scalp cooling is an increasingly recognized non-pharmacologic approach to minimize chemotherapy-induced alopecia (CIA). Several commercially available machine-based and manual scalp cooling systems are available; however, literature reports of effectiveness are highly variable. The purpose of this study was to determine real-world tolerability and subjective effectiveness of a manual cold capping system in minimizing CIA across a variety of patient race and hair types. This study was a single-institution review of outcomes from manual cold capping.

Methods: We identified retrospective cohort of adult patients who presented to discuss cold capping between January 14, 2019, and March 31, 2022. Data collected from medical records included demographics, decision to pursue/continue cold capping, diagnoses, chemotherapy regimens, hair characteristics (length, thickness, coarseness, type), and subjective perception of percentage of hair retained. Those with successful vs. unsuccessful cold capping (≥ 50% vs. < 50% of hair retained) were compared based on the patient-level factors of interest.

Findings: A total of 100 patients initiated cold capping during the study period, and 95% of them completed cold capping. The majority of patients who started cold capping completed it. The median-reported percentage of hair maintained was 75%, and 82/89 (92.1% of patients) had favorable results, defined as ≥ 50% of hair retained. The only patient-level factor associated with favorable response was chemotherapy regimen, with fewer patients receiving doxorubicin-containing regimens having successful hair retention compared to other chemotherapy types (71.4% successful results vs. 95.7% for those receiving paclitaxel-containing regimens and 96.6% for those receiving docetaxel-containing regimens (p = 0.018). There was no difference in success based on patient race/ethnicity or hair characteristics.

Interpretation: The overall effectiveness (92.1%) in this study is consistent to higher than many literature reports. One possible reason for the high success in our cohort is compliance with cold capping protocols, meaning applying the cap in the appropriate manner and wearing the cap for the prescribed durations, which may impact effectiveness.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933155PMC
http://dx.doi.org/10.1007/s00520-024-08393-7DOI Listing

Publication Analysis

Top Keywords

cold capping
16
chemotherapy-induced alopecia
8
scalp cooling
8
manual cold
8
cold
6
retrospective evaluation
4
evaluation penguin
4
penguin cold
4
cold caps
4
caps chemotherapy-induced
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!